Skip to content
Announcement:

New scientific publication in collaboration with the University of Newcastle on modelling Stargardt disease (STGD1) in vitro with retinal organoids (RO) to unravel genotype-phenotype correlations

Creating a Powerful NAM respiratory Toxicology Strategy for Clinical Predictivity and IND success

During this fireside chat session, you will hear our 2 guest speakers discuss how to best devise a NAM (new approach methodologies) strategy to progress your respiratory compound through the pipeline including standardisation, trends and innovations in respiratory in-vitro models.

Speakers:

  • Dr Clive Roper – Director – Roper Toxicology Consulting Limited
  • Dr Megan Webster – Former Head of Lung – Newcells Biotech

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.


Get our latest updates straight to your inbox

Book a Call